These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 975177

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.
    Shimamoto T, Atsumi T.
    Jpn Heart J; 1965 Sep; 6(5):407-15. PubMed ID: 5294603
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of atherosclerosis obliterans with pyridinolcarbamate.
    Atsumi T, Motomiya T, Isokane N, Shimamoto T.
    Jpn Heart J; 1971 Jul; 12(4):335-46. PubMed ID: 5314713
    [No Abstract] [Full Text] [Related]

  • 25. [Prodectin treatment of partial hearing loss as a result of atherosclerosis].
    Smirnova NA, Timakov VA, Mikushkin MK.
    Vestn Otorinolaringol; 1982 Jul; (6):53-6. PubMed ID: 7179649
    [No Abstract] [Full Text] [Related]

  • 26. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV.
    Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Effect of complamin and prodectin on microcirculation and lipid metabolism in psoriasis patients].
    Rakhmatov AB, Bilash NV.
    Vestn Dermatol Venerol; 1983 Apr; (4):15-8. PubMed ID: 6868813
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A multiclinic double-blind trial of pyridinolcarbamate and inositol niacinate in ischemic ulcer due to chronic arterial occlusion.
    Mishima Y, Kamiya K, Sakaguchi S, Kusaba A, Sakuma A.
    Angiology; 1977 Feb; 28(2):84-94. PubMed ID: 326097
    [Abstract] [Full Text] [Related]

  • 35. Attempts to delay progression in occlusive atherosclerosis.
    Terry EN, Rouen LR, Clasuss RH, Katz MC, Redisch W.
    Ann N Y Acad Sci; 1976 Feb; 275():379-85. PubMed ID: 1070279
    [No Abstract] [Full Text] [Related]

  • 36. Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans.
    Shimamoto T, Atsumi T, Yamashita S, Motomiya T, Isokane N, Ishioka T, Sakuma A.
    Am Heart J; 1970 Jan; 79(1):5-19. PubMed ID: 4903137
    [No Abstract] [Full Text] [Related]

  • 37. [A double blind crossover trial in pyridinolcarbamate treatment of atherosclerosis obliterans].
    Yamashita S.
    Nihon Naika Gakkai Zasshi; 1969 Apr 10; 58(4):283-92. PubMed ID: 4896659
    [No Abstract] [Full Text] [Related]

  • 38. [Treatment of arteriosclerosis obliterans with pyridinolcarbamate].
    Atsumi T, Isokane N, Yamashita S, Sano T, Odakura T, Kurai A.
    Nihon Naika Gakkai Zasshi; 1967 Sep 10; 56(9):983-92. PubMed ID: 5627161
    [No Abstract] [Full Text] [Related]

  • 39. [Biopharmaceutical studies on pyridinolcarbamate. I. Effect of continuous pyridinolcarbamate administration on renal excretion of sulfonamides in rabbits (author's transl)].
    Ichibagase H, Imamura Y, Suenaga A, Kawabata H.
    Yakugaku Zasshi; 1978 Nov 10; 98(10):1398-402. PubMed ID: 745048
    [No Abstract] [Full Text] [Related]

  • 40. [Comparison of the effectiveness of anginin and stugeron treatment of cerebral arteriosclerosis].
    Sobczyk W, Kruszewska J, Szymchel J.
    Neurol Neurochir Pol; 1980 Nov 10; 14(2):183-9. PubMed ID: 6993976
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.